Pharmaceutical Industry Faces Legal Challenges Amid AI Integration in Drug Development, Bain & Company Study Reveals
Generative artificial intelligence (AI) is increasingly becoming a focal point for pharmaceutical leaders as it promises to transform drug discovery, preclinical testing, and clinical trials. With the potential for significant cost savings and monetary benefits, this AI-driven transformation is not without its legal risks. Companies must address potential issues related to product liability, intellectual property,…